Skandinaviska Enskilda Banken Ab (Publ) Jazz Pharmaceuticals PLC Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

  • $21.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$121.81 - $142.95 $6.29 Million - $7.38 Million
-51,612 Closed
0 $0
Q4 2018

Feb 12, 2019
SELL
$115.94 - $166.74 $131,475 - $189,083
-1,134 Reduced 2.15%
51,612 $6.4 Million
Q3 2018

Nov 05, 2018
BUY
$161.01 - $180.57 $8.49 Million - $9.52 Million
52,746 New
52,746 $8.87 Million

Others Institutions Holding JAZZ

# of Institutions
513
Shares Held
57.7M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.62B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email